Insider: Carter Todd Alfred Chief Scientific Officer - Voyager Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 77,718 | 0 | 77,718 |
| Value | $351,285.36 | $0.00 | $351,285.36 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/20/2025 | DDS | 3,305 | Direct | COM | $4.26 | $14,079.30 | 77,718 |
| 02/11/2025 | DDS | 5,413 | Direct | COM | $4.45 | $24,087.85 | 81,023 |
| 01/14/2025 | DDS | 1,191 | Direct | COM | $5.13 | $6,109.83 | 86,436 |
| 02/21/2024 | DDS | 3,365 | Direct | COM | $7.47 | $25,136.55 | 87,627 |
| 02/20/2024 | DDS | 602 | Direct | COM | $7.68 | $4,623.36 | 90,992 |
| 01/17/2024 | DDS | 1,266 | Direct | COM | $7.18 | $9,089.88 | 53,094 |
| 09/15/2023 | DDS | 10,500 | Direct | COM | $8.16 | $85,680.00 | 54,360 |
| 07/06/2023 | DDS | 5,500 | Direct | COM | $10.80 | $59,400.00 | 59,860 |
| 06/30/2023 | DDS | 5,000 | Direct | COM | $11.41 | $57,050.00 | 65,360 |
| 03/20/2023 | DDS | 2,193 | Direct | COM | $7.76 | $17,017.68 | 65,360 |
| 02/17/2023 | DDS | 738 | Direct | COM | $7.45 | $5,498.10 | 67,553 |
| 02/13/2023 | DDS | 797 | Direct | COM | $7.67 | $6,112.99 | 34,291 |
| 01/17/2023 | DDS | 400 | Direct | COM | $10.34 | $4,136.00 | 35,088 |
| 01/17/2023 | DDS | 706 | Direct | COM | $9.57 | $6,756.42 | 35,488 |
| 01/06/2023 | DDS | 388 | Direct | COM | $6.41 | $2,487.08 | 36,194 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research